12 Month Price Forecast For MPLN
Distance to MPLN Price Forecasts
MPLN Price Momentum
🤔 Considering MultiPlan (MPLN)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: February 8, 2025 4:13 AM UTC
MPLN Analyst Ratings & Price Targets
Based on our analysis of 6 Wall Street analysts, MPLN has a consensus that is neutral. The median price target is $11.25, with forecasts ranging from $10.00 to $12.50. Currently, there are 1 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
With MPLN currently trading at $23.66, the median price forecast suggests a -52.5% downside. The most optimistic forecast comes from Daniel Grosslight at Citigroup, projecting a -47.2% downside, while Daniel Grosslight at Citigroup provides the most conservative target, suggesting a -57.7% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MPLN Analyst Consensus
MPLN Price Target Range
Latest MPLN Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MPLN.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jan 10, 2025 | Citigroup | Daniel Grosslight | Neutral | Maintains | $12.50 |
| Sep 23, 2024 | Citigroup | Daniel Grosslight | Neutral | Maintains | $10.00 |
| Aug 7, 2024 | Piper Sandler | Jessica Tassan | Neutral | Reiterates | $1.00 |
| Jun 26, 2024 | Piper Sandler | Jessica Tassan | Neutral | Initiates | $2.00 |
| Mar 8, 2023 | Citigroup | Daniel Grosslight | Neutral | Maintains | $1.25 |
| Jan 18, 2023 | Barclays | Marc Solecitto | Equal-Weight | Maintains | $1.00 |
| Dec 13, 2022 | Citigroup | Daniel Grosslight | Neutral | Downgrade | $2.00 |
| Nov 16, 2022 | Goldman Sachs | Cindy Motz | Neutral | Maintains | $2.05 |
| Nov 9, 2022 | Citigroup | Daniel Grosslight | Buy | Maintains | $3.00 |
| Jul 12, 2022 | Goldman Sachs | Cindy Motz | Neutral | Initiates | $6.50 |
| May 11, 2022 | Citigroup | Daniel Grosslight | Buy | Maintains | $6.50 |
| Dec 20, 2021 | Citigroup | Buy | Maintains | $7.00 | |
| Nov 11, 2021 | Barclays | Steve Valiquette | Equal-Weight | Maintains | $6.00 |
| Aug 20, 2021 | Tigress Financial | Buy | Initiates | $0.00 | |
| Apr 7, 2021 | B. Riley FBR | Buy | Initiates | $0.00 | |
| Apr 7, 2021 | B. Riley Securities | Buy | Initiates | $0.00 | |
| Mar 19, 2021 | Barclays | Equal-Weight | Initiates | $0.00 | |
| Nov 17, 2020 | Citigroup | Buy | Initiates | $0.00 | |
| Nov 16, 2020 | Citigroup | Buy | Initiates | $0.00 |
Stocks Similar to MultiPlan Corporation
The following stocks are similar to MultiPlan based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
MultiPlan Corporation (MPLN) Financial Data
MultiPlan Corporation has a market capitalization of $381.14M with a P/E ratio of -4.2x. The company generates $942.61M in trailing twelve-month revenue with a -163.3% profit margin.
Revenue growth is -5.1% quarter-over-quarter, while maintaining an operating margin of +10.2% and return on equity of -157.3%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
MultiPlan Corporation (MPLN) Company Overview
About MultiPlan Corporation
Provides healthcare cost management and analytics solutions.
The company generates revenue by offering data analytics and technology-driven services that help healthcare organizations reduce medical costs. MultiPlan utilizes data-driven algorithms to identify overcharges and negotiate reimbursements, while also providing contracted discounts and outsourced network management services. Additionally, its payment and revenue integrity solutions assist clients in identifying improper charges and recovering underpaid premiums.
Founded in 1980 and headquartered in New York, MultiPlan serves a diverse client base, including national and regional insurance companies, health plans, and third-party administrators. Its suite of services leverages modern data science methodologies to support decision-making and enhance clinical outcomes, positioning the company as a key player in the healthcare cost management sector.
Company Information
Sector
Healthcare
Industry
Health Information Services
Employees
2,800
CEO
Mr. Travis S. Dalton
Country
United States
IPO Year
2020
Website
www.multiplan.usMultiPlan Corporation (MPLN) Latest News & Analysis
MultiPlan Corporation Announces Fourth Quarter and Full Year 2024 Earnings Conference Call
11 days agoMultiPlan Corporation will hold an earnings conference call for its fourth quarter and full year 2024 results.
The announcement of MultiPlan's earnings call indicates upcoming financial performance insights, crucial for assessing the company's health and future investment potential.
MultiPlan Corporation (NYSE: MPLN) announced the expiration and results of its Exchange Offers for its 5.50% Senior Secured Notes due 2028, aimed at improving cost management in healthcare.
The expiration of MultiPlan's exchange offers for senior secured notes may affect the company's capital structure and liquidity, influencing investor sentiment and stock performance.
MultiPlan (MPLN) shares rose on above-average trading volume, but recent earnings estimate revisions indicate potential weakness ahead.
MultiPlan's share price surge on high volume indicates short-term interest, but stagnant earnings estimates signal potential long-term weakness, affecting future investment decisions.
MultiPlan Corporation (NYSE: MPLN) will consolidate its cloud infrastructure on Oracle Cloud Infrastructure to enhance efficiency and support its digital transformation strategy.
MultiPlan's consolidation on Oracle Cloud enhances operational efficiency and flexibility, potentially boosting performance and client satisfaction, which could positively impact stock performance.
MultiPlan and J2 Health Announce Strategic Agreement to Enhance Network Services and Analytics
28 days agoMultiPlan Corporation (NYSE: MPLN) has entered a strategic agreement with J2 Health to enhance provider network performance, supporting its network optimization strategy and improving healthcare cost efficiency.
The agreement enhances MultiPlan's service offerings, potentially improving operational efficiency and profitability, which can positively influence stock performance and investor confidence.
MultiPlan Announces Comprehensive Refinancing
1 month agoMultiPlan Corporation (NYSE: MPLN) has announced a comprehensive refinancing to extend the maturities of its entire debt capital structure, securing agreements with certain noteholders and lenders.
MultiPlan's refinancing extends debt maturities, reducing immediate financial pressure and improving stability, which could enhance investor confidence and potentially stabilize stock performance.
Frequently Asked Questions About MPLN Stock
What is MultiPlan Corporation's (MPLN) stock forecast for 2025?
Based on our analysis of 6 Wall Street analysts, MultiPlan Corporation (MPLN) has a median price target of $11.25. The highest price target is $12.50 and the lowest is $10.00.
Is MPLN stock a good investment in 2025?
According to current analyst ratings, MPLN has 1 Buy ratings, 2 Hold ratings, and 0 Sell ratings. The stock is currently trading at $23.66. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for MPLN stock?
Wall Street analysts predict MPLN stock could reach $11.25 in the next 12 months. This represents a -52.5% decrease from the current price of $23.66. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is MultiPlan Corporation's business model?
The company generates revenue by offering data analytics and technology-driven services that help healthcare organizations reduce medical costs. MultiPlan utilizes data-driven algorithms to identify overcharges and negotiate reimbursements, while also providing contracted discounts and outsourced network management services. Additionally, its payment and revenue integrity solutions assist clients in identifying improper charges and recovering underpaid premiums.
What is the highest forecasted price for MPLN MultiPlan Corporation?
The highest price target for MPLN is $12.50 from Daniel Grosslight at Citigroup, which represents a -47.2% decrease from the current price of $23.66.
What is the lowest forecasted price for MPLN MultiPlan Corporation?
The lowest price target for MPLN is $10.00 from Daniel Grosslight at Citigroup, which represents a -57.7% decrease from the current price of $23.66.
What is the overall MPLN consensus from analysts for MultiPlan Corporation?
The overall analyst consensus for MPLN is neutral. Out of 6 Wall Street analysts, 1 rate it as Buy, 2 as Hold, and 0 as Sell, with a median price target of $11.25.
How accurate are MPLN stock price projections?
Stock price projections, including those for MultiPlan Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
